Obstetrics. Gynecology. Best marriage
Please sign in so that we can notify you about a reply
The second edition of the leadership is devoted to the expansion of the necessary modern knowledge by clinical pharmacology as obstetrician-gynecologists. It is due, first of all, progressing changes in the rules for the appointment of certain drugs. On December 25, 2018, the President of the Russian Federation signed a decree on the mandatory recommendations as a document in accordance with which medicines in Russia should be prescribed. Awareness of the new stage of the possibility/impossibility of prescribing drugs, the fight against polypraggmasia, prescribing unnecessary or inconsistent drugs, especially pregnant women, the need for consultations of relevant specialists in the treatment of extragenital diseases of pregnant women and participation in the consultations of clinical pharmacologists - an interdisciplinary approach to treatment from the perspective of evidence -based medicine, all this has become legal requirements for the practical activities of doctors.
As in the first edition, this leadership reflects basic information about regulatory documents allowing /prohibiting the use of pharmacological drugs, outlines the procedure for receipt of drugs and the procedure for their certification in the country, and the characteristics of drugs used in obstetrics and gynecology are shortly given , reference information is presented that facilitates the rational choice of the drug, in accordance with the procedure for the provision of obstetric and gynecological care and clinical recommendations as the main document regulating the appointment of certain drugs.
The publication, as before, is the only regularly updated source of instructions officially approved in the country for medical use of drugs, namely the state register of medicines of the Russian Federation.
The leadership continues a series of publications created in accordance with the Strategy for the Development of Medical Science in the Russian Federation until 2025
Designed for obstetrician-gynecologists, general practitioners, heads of medical institutions, residents, cadets of all forms of continuous medical education with a degree in obstetrics and gynecology, as well as senior students of medical universities.
2nd edition, processed and supplemented
As in the first edition, this leadership reflects basic information about regulatory documents allowing /prohibiting the use of pharmacological drugs, outlines the procedure for receipt of drugs and the procedure for their certification in the country, and the characteristics of drugs used in obstetrics and gynecology are shortly given , reference information is presented that facilitates the rational choice of the drug, in accordance with the procedure for the provision of obstetric and gynecological care and clinical recommendations as the main document regulating the appointment of certain drugs.
The publication, as before, is the only regularly updated source of instructions officially approved in the country for medical use of drugs, namely the state register of medicines of the Russian Federation.
The leadership continues a series of publications created in accordance with the Strategy for the Development of Medical Science in the Russian Federation until 2025
Designed for obstetrician-gynecologists, general practitioners, heads of medical institutions, residents, cadets of all forms of continuous medical education with a degree in obstetrics and gynecology, as well as senior students of medical universities.
2nd edition, processed and supplemented
Author:
Author:Radzinsky Viktor Evseevich, Novginov, Novginov Dmitry Sergeevich, Shikh Evgenia Valerievna
Cover:
Cover:Soft
Category:
- Category:Medical Books
Publication language:
Publication Language:Russian
Paper:
Paper:Offset
ISBN:
ISBN:978-5-9704-6031-3
No reviews found